|

Disease-Modifying Therapies (DMTs) Clinical Trials

1 actively recruiting trial across 1 location

Top Sponsors

  • SetPoint Medical Corporation1

Indications

  • Relapsing Remitting Multiple Sclerosis1
  • Multiple Sclerosis1

Atlanta, Georgia1 trial

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Shepherd Center

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.